Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: A pilot study

Annals of Nuclear Medicine

Volumn 28, Issue 6, 2014, Pages 571-579

  Niccoli Asabella, Artor ^a   Ciccone, Marco M ^a   Cortese, Francesca ^a   Scicchitano, Pietro ^a   Gesualdo, Michele ^a   Zito, Annapaola ^a   Di Palo, Alessandra ^a   Angiletta, Domenico ^a   Regina, Guido ^a   Marzullo, Andrea ^a   Rubini, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Histology; PET CT; Vulnerable carotid plaques

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ANALYTICAL PARAMETERS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MICROSCOPY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; STANDARDIZED UPTAKE VALUE; STATISTICAL SIGNIFICANCE; TARGET BACKGROUND RATIO; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; DIAGNOSTIC USE; ECHOGRAPHY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84904397553     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-014-0850-9     Document Type: Article

References (37)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125:188-97.
2. Sitzer M, Trostdorf F. The unstable carotid stenosis: definition and biological processes. Hamostaseologie. 2003;23:61-6. (Pubitemid 36741000)
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420: 868-74. (Pubitemid 36019640)
4. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, et al. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65:794-801. (Pubitemid 41362117)
5. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gerwitz H, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301. (Pubitemid 40790404)
6. de Vries Wallis BM, van Dam GM, Tio RA, Hillebrands JL, Slart RH, Zeebregts CJ. Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque. J Vasc Surg. 2008;48:1620-9.
7. Meerwaldt R, Slart RH, van Dam GM, Luijckx GJ, Tio RA, Zeebregts CJ. PET/SPECT imaging: from carotid vulnerability to brain viability. Eur J Radiol. 2010;74:104-9.
8. Tahara N, Kai H, Nakaura H, Mizoguchi M, Ishibashi M, Kaida H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J. 2007;28:2243-8. (Pubitemid 47428937)
9. Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-50. (Pubitemid 47611672)
10. Riou LM, Broisat A, Dimastromatteo J, Pons G, Fagret D, Ghezzi C. Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview. Curr Med Chem. 2009;16:1499-511.
11. Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5:69-77.
12. Eckstein HH. Evidence-based management of carotid stenosis: recommendations from international guidelines. J Cardiovasc Surg (Torino). 2012;53:S3-13.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751-62. (Pubitemid 47356612)
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62-9.
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-421.
16. Mart'nez JA, Kearney JM, Kafatos A, Paquet S, Mart'nez-González MA. Variables independently associated with self-reported obesity in the European Union. Public Health Nutr. 1999; 2:125-33. (Pubitemid 29230009)
17. Silberberg JS, Wlodarczyk J, Fryer J, Robertson R, Hensley MJ. Risk associated with various definitions of family history of coronary heart disease. The Newcastle Family History Study II. Am J Epidemiol. 1998;147:1133-9. (Pubitemid 28285455)
18. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc Dis. 2007;23:75-80.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-406. (Pubitemid 17189260)
20. Arnold JA, Modaresi KB, Thomas N, Taylor PR, Padayachee TS. Carotid plaque characterization by duplex scanning: observer error may undermine current clinical trials. Stroke. 1999;30:61-5.
21. Kim TY, Choi JB, Kim KH, Kim MH, Shin BS, Park HK. Routine shunting is safe and reliable for cerebral perfusion during carotid endarterectomy in symptomatic carotid stenosis. Korean J Thorac Cardiovasc Surg. 2012;45:95-100.
22. Hellings WE, Pasterkamp G, Vollebregt A, Seldenrijk CA, De Vries JP, Velema E, et al. Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. J Vasc Surg. 2007;46:1147-54. (Pubitemid 350267075)
23. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-24. (Pubitemid 44648622)
24. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]- fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-11. (Pubitemid 34615139)
25. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-31. (Pubitemid 44648621)
26. Chen W, Dilsizian V. (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation. Curr Cardiol Rep. 2010;12:179-84.
27. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages. J Am Coll Cardiol. 2011;58: 603-14.
28. Sheikine Y, Akram K. FDG-PET imaging of atherosclerosis: Do we know what we see? Atherosclerosis. 2010;211:371-80.
29. Graebe M, Pedersen SF, Højgaard L, Kjaer A, Sillesen H. 18FDG PET and ultrasound echolucency in carotid artery plaques. JACC Cardiovasc Imaging. 2010;3:289-95.
30. Martinet W, Schrijvers DM, De Meyer GR. Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Res Cardiol. 2012;107:297.
31. Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification, methods, and recommendations. J Nucl Med. 2008;49:871-8. (Pubitemid 351793426)
32. Shepherd PR, Kahn BB. Glucose transporters and insulin action implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341:248-57. (Pubitemid 29334524)
33. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-Dglucose in rodents with mammary carcinoma. Radiology. 1992;183:643-7.
34. Deichen JT, Prante O, Gack M, Schmiedehause K, Kuwert T. Uptake of [(18)F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003;30:267-73. (Pubitemid 36686846)
35. Niccoli Asabella A, Iuele FI, Merenda N, Pisani AR, Notaristefano A, Rubini G. 18F-FDG PET/CT diabetes and hyperglycaemia. Nucl Med Rev Cent East Eur. 2013;16(2):57-61.
36. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-15.
37. Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P, Weber C, et al. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride. J Nucl Med. 2011;52:362-8.